2D Antiscatter Grids on CBCT for Cancer Imaging Quality
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment 2D Antiscatter Grids in improving cancer imaging quality?
Research shows that two-dimensional antiscatter grids (2D grids) can significantly reduce scattered radiation, which improves image quality in cone-beam computed tomography (CBCT) by enhancing contrast and reducing noise. These grids are particularly effective in high scatter conditions, providing better image clarity compared to traditional one-dimensional grids.12345
Is the use of 2D Antiscatter Grids in CBCT imaging safe for humans?
The research suggests that 2D Antiscatter Grids in CBCT imaging are generally safe, as they improve image quality by reducing x-ray scatter without significant adverse effects. However, precise alignment is necessary to maintain image quality, and the use of grids is most beneficial under specific conditions of high x-ray scatter.12678
How does the 2D antiscatter grid treatment in CBCT differ from other cancer imaging treatments?
The 2D antiscatter grid treatment in CBCT is unique because it uses a two-dimensional grid to significantly reduce scattered radiation, which improves image quality by enhancing contrast and reducing artifacts. This approach is particularly effective in high scatter conditions, offering better image clarity compared to traditional one-dimensional grids used in other imaging treatments.12349
What is the purpose of this trial?
This is Pilot study that investigates the CBCT(Cone beam computed tomography) image quality improvement provided by the 2D antiscatter grid technology. The primary objective is to assess the improvement in tissue visualization in an observer study, which will be conducted in a blinded fashion.
Research Team
Cem Altunbas, PhD
Principal Investigator
University of Colorado, Denver
Eligibility Criteria
This trial is for adults aged 18-100 who are undergoing CBCT-guided therapy for certain cancers in the upper abdomen, prostate, or head and neck. They must be able to lie still during imaging and treatment, sign a consent form, follow study procedures, and not have metallic implants in the scan area (some dental materials may be okay). Pregnant individuals cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Imaging
Participants are scanned with a CBCT system equipped with 2D antiscatter grid technology and a standard clinical CBCT for baseline comparison
Observer Study
Assessment of image quality improvement in research CBCT compared to standard clinical CBCT in a blinded observer study
Follow-up
Participants are monitored for safety and effectiveness after imaging
Treatment Details
Interventions
- 2D Antiscatter Grids
- Research CBCT
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
National Cancer Institute (NCI)
Collaborator